1. Introduction {#sec1-medicines-04-00034}
===============

*Tanacetum vulgare* L. is a perennial herb of the Asteraceae family. This plant grows widely in Europe and Asia. Introduced into North America in the 18th century, it is well adapted to northern climates \[[@B1-medicines-04-00034]\]. Traditionally, *T. vulgare* has been used as an anthelmintic, tonic, emmenagogue, antihypertensive, carminative, antispasmodic, antidiabetic, diuretic, and an anti-inflammatory compound \[[@B2-medicines-04-00034],[@B3-medicines-04-00034]\]. Most alcohol extracts of *T. vulgare* are reported to have biological effects including anti-inflammatory, antioxidant, and antibacterial properties. Indeed, studies on rats and mice \[[@B4-medicines-04-00034],[@B5-medicines-04-00034]\] have found *T. vulgare* extracts to have anti-inflammatory properties. Flavonoids present in the plant could be, in part, responsible for these biological effects \[[@B5-medicines-04-00034],[@B6-medicines-04-00034]\]. Shinella et al. demonstrated that parthenolide was the main in vivo anti-inflammatory substance in *T. vulgare* \[[@B5-medicines-04-00034]\]. Methanol extracts from *T. vulgare* showed antioxidant activity, probably due to the presence of phenolic compounds \[[@B7-medicines-04-00034]\]. The antibacterial properties of ethanolic extracts have also been reported in studies using *Escherichia coli* and *Staphylococcus aureus* \[[@B8-medicines-04-00034],[@B9-medicines-04-00034]\].

Regional variability of the chemical composition of *T. vulgare* essential oils is well-known and many essential oil chemotypes have been reported in the literature \[[@B10-medicines-04-00034],[@B11-medicines-04-00034],[@B12-medicines-04-00034],[@B13-medicines-04-00034],[@B14-medicines-04-00034],[@B15-medicines-04-00034],[@B16-medicines-04-00034],[@B17-medicines-04-00034],[@B18-medicines-04-00034],[@B19-medicines-04-00034],[@B20-medicines-04-00034],[@B21-medicines-04-00034]\]. For example, *T. vulgare* essential oil chemotypes from Hungary and Argentina are mainly composed of β-thujone (72.4% and 91.65%, respectively) \[[@B15-medicines-04-00034],[@B20-medicines-04-00034]\]. However, *T. vulgare* essential oil chemotypes from Finland and Lithuania \[[@B10-medicines-04-00034],[@B12-medicines-04-00034]\] had, respectively, artemisia ketone (55.08% to 81.36%) and 1,8-cineole (3.6% to 39.7%) as the main constituents. Kumar et al. \[[@B22-medicines-04-00034]\] have thoroughly reviewed this chemotype variability of *Tanacetum*. Despite the many regional chemotypes, many studies of the biological effects of *T. vulgare* essential oils did not analyze the complete chemical composition of the oils nor its constituents in relation to their biological properties.

In our study, the essential oil of *T. vulgare*, collected from an area in northern Quebec (Saguenay-Lac-St-Jean, Chicoutimi, QC, Canada), was extracted by steam distillation and analyzed using GC-FID (Agilent Technologies, Santa Clara, CA, USA). We assessed the essential oils and its constituents for anti-inflammatory, antioxidant, antibacterial, and cytotoxic activities.

2. Experimental Section {#sec2-medicines-04-00034}
=======================

2.1. Chemicals {#sec2dot1-medicines-04-00034}
--------------

We used standard compounds for GC analyses and biological testing from Sigma-Aldrich (St. Louis, MO, USA) (1,8-cineole, bornyl acetate, α-terpinene, β-pinene, α-pinene, γ-terpinene, ρ-cymene, camphene, camphor, caryophyllene oxide, limonene, terpinene-4-ol, terpinolene), Fluka (Fluka Chemie GmbH, Buchs, Switzerland) (α-humulene), and Takasago (Takasago International Corporation, Tokyo, Japan) (β-caryophyllene).

2.2. Plant Material and Extraction of Essential Oil {#sec2dot2-medicines-04-00034}
---------------------------------------------------

The aerial portions of *T. vulgare* were collected in July 2014 in Chicoutimi, Quebec, QC, Canada. Voucher specimen no. QFA0610840 has been filed at the Louis-Marie herbarium of Laval University, Quebec, QC, Canada. Essential oil was obtained from freshly harvested aerial parts by industrial steam distillation over a 3-h period (Groupe BoréaRessources, Ferland-Boileau, QC, Canada). The essential oil extraction yields depended on the total amount of the raw material. The extracted essential oil was then stored in the dark at a temperature of 4 °C.

2.3. GC-MS Analysis {#sec2dot3-medicines-04-00034}
-------------------

All chromatographic analyses were run on an Agilent 6890N GC (Agilent Technologies, Santa Clara, CA, USA) equipped with a non-polar DB-5 column (Agilent Technologies, Santa Clara, CA, USA) and a polar SolGel-Wax column (30 m × 0.25 mm × 0.25 mm) (Agilent Technologies, Santa Clara, CA, USA) as well as two FID detectors (Agilent Technologies, Santa Clara, CA, USA). The oils were injected in an undiluted (0.1 µL injection volume, split 1:235) and undried state. The temperature program was 40 °C for 2 min, 2 °C·min^−1^ up to 210 °C, and then 210 °C for 13 min. Samples were also injected on an Agilent 7890A GC (Agilent Technologies, Santa Clara, CA, USA) coupled to an Agilent 5975C InertXL EI/CI mass spectrometer (Agilent Technologies, Santa Clara, CA, USA), equipped with a DB-5MS column (Agilent Technologies, Santa Clara, CA, USA) using the same temperature program as above and a split of 1:1000. Compounds were identified from their retention indexes as calculated from even-numbered C8 to C36 alkane standards and/or from MS databases NIST08, HPCH 2205 and custom libraries built from pure compounds (Laboratoire LASEVE, UQAC, QC, Canada). Quantification was derived from the FID detector response on the DB-5 column without any correction factor. All standards were co-injected to validate the identification.

2.4. Cell Culture {#sec2dot4-medicines-04-00034}
-----------------

Human skin fibroblasts WS1 (ATCC CRL-1502), human lung carcinoma A-549 (ATCC CCL-185), human colon adenocarcinoma DLD-1 (ATCC CCL-221), and murine macrophage RAW 264.7 (ATCC TIB-71) were obtained from the American Type Culture Collection (Manassas, VA, USA). The human keratinocytes *HaCaT* cell line was obtained from Dr. Mammoud Rouhabia (Laval University, Québec, QC, Canada). Cells were grown in a humidified atmosphere at 37 °C in 5% CO~2,~ in Dulbecco's Minimum Essential Medium supplemented with 10% fetal calf serum (Hyclone, Logan, UT, USA), 1 × solution of sodium pyruvate, 1 × vitamins, 1 × non-essential amino acids, 100 IU of penicillin and 100 µg·mL^−1^ streptomycin (Cellgro^®^, Mediatech, Manassas, VA, USA).

2.5. Measurement of Anti-Inflammatory Activity {#sec2dot5-medicines-04-00034}
----------------------------------------------

We evaluated the inhibition NO production by *T. vulgare* essential oil and compounds as described by Legault et al. \[[@B23-medicines-04-00034]\]. Control L-NAME was used as positive control. Murine macrophage RAW 264.7 cells were incubated with essential oil or dissolved compounds in DMSO and then stimulated with 100 ng·mL^−1^ LPS and incubated at 37 °C. After 24 h, we collected the cell-free supernatants and immediately determined the NO concentration using the Griess reaction. We read the absorbance at 540 nm using an automated Varioskan Ascent plate reader (Labsystems, Milford, MA, USA), and quantified the presence of nitrite by comparing with a NaNO~2~ standard curve.

2.6. Evaluation of Antioxidant Activity Using Cell-Based Assays {#sec2dot6-medicines-04-00034}
---------------------------------------------------------------

Antioxidant activity was evaluated using the DCFH-DA assay as described by Girard-Lalancette et al. \[[@B24-medicines-04-00034]\]. To assess antioxidant activity, we incubated the human skin fibroblasts WS1 for 1 h with a growing concentration of essential oil or dissolved compounds in DMSO. We then added 100 µL of 200 µM tert-butylhydroperoxide and immediately measured fluorescence as well as again after 90 min later. Measurements were performed on an automated plate reader (Fluoroskan Ascent FL, Labsystems, Milford, MA, USA) using an excitation wavelength of 485 nm and an emission wavelength of 530 nm. Antioxidant activity was expressed as the concentration of extract inhibiting 50% (IC~50~) of DCFH oxidation.

2.7. Evaluation of Antibacterial Activity {#sec2dot7-medicines-04-00034}
-----------------------------------------

We tested the antibacterial activities of *T. vulgare* essential oil and compounds against gram-negative *Escherichia coli* (ATCC bacteria 25922) and gram-positive *Staphylococcus aureus* (ATCC bacteria 25923) using the antibacterial hydrophobic assay as described by Côté et al. \[[@B25-medicines-04-00034]\]. This new method was developed and used in this work as classical methods including disc diffusion and microdilution assays are sometimes inefficient for testing a matrix or compounds of a hydrophobic nature. Briefly, after microorganisms passed 16--18 h at 37 °C in a nutrient broth base (Difco), we transferred 20 µL methanol containing growing concentrations of essential oil and compounds (3.1 to 200 µg·mL^−1^) onto nutrient agar of 96-well plates. We then added bacterial strains having a concentration of 5 × 10^3^ colony forming units (CFU) per mL of nutrient broth. Bacterial suspension without treatment was used as negative control and bacterial suspension plus solvent was tested in parallel to demonstrate the absence of solvent toxicity. The blank consisted of culture medium only and was subtracted from all subsequent measurements of every other well. The 96-well plates were then incubated at 37 °C for 5 h to foster bacterial growth. We then added 100 µL of resazurin sodium salt solution having a concentration of 50 µg·mL^−1^ (Sigma R-2127, St-Louis, MO, USA) to each well. Fluorescence was read on an automated Fluoroskan Ascent FL^TM^ plate reader (Labsystems, Milford, MA, USA) after two hours for *S. aureus* and three hours for *E. coli*. The IC~50~ was determined as the lowest concentration resulting in 50% inhibition of bacterial growth.

2.8. Cytotoxic Assays {#sec2dot8-medicines-04-00034}
---------------------

We plated in 96-well microplates---each containing a 100 µL culture medium---exponentially growing cells of human skin fibroblasts WS1, human *HaCaT* keratinocytes, human lung carcinoma A-549, and human colon adenocarcinoma DLD-1 at a density of 5 × 10^3^ cells per well (Costar, Corning Inc., Lowell, MA, USA). The cells were allowed to adhere for 16 h before treatment. We then treated cells with *T. vulgare* essential oil or dissolved compounds in DMSO. The final concentration of DMSO in the culture medium was 0.5% (*v/v*) to avoid solvent toxicity. After 48 h, we assessed the cytotoxicity using the resazurin reduction test \[[@B26-medicines-04-00034]\]. Fluorescence was measured on an automated Fluoroskan Ascent FL^TM^ plate reader (Labsystems, Milford, MA, USA) using an excitation wavelength of 530 nm and an emission wavelength of 590 nm. Cytotoxicity was expressed as the concentration that inhibited cell growth by 50% (IC~50~).

3. Results and Discussion {#sec3-medicines-04-00034}
=========================

The essential oil of *T. vulgare* obtained by steam distillation method was yellow with a distinct odor. The extraction yield obtained after 3 h was 0.23% (*w*/*w*). The refraction index was 1.4797, and the density measured using pycnometer was 0.92396 g·mL^−1^. [Table 1](#medicines-04-00034-t001){ref-type="table"} presents the chemical composition of the essential oil as determined by GC-FID analysis. The oil was mainly comprised of oxygenated monoterpenes such as camphor (30.48%), borneol (14.80%), and 1,8-cineole (10.80%). The essential oil also contained camphene (7.29%), bornyl acetate (5.53%), and α-pinene (4.43%). Our results confirm the findings of Collin et al. \[[@B17-medicines-04-00034]\] for *T. vulgare* essential oil from northern Quebec.

We evaluated the biological properties of *T. vulgare* essential oil, including anti-inflammatory, antioxidant, antibiotic, and cytotoxic effects, in vitro using cellular models. Our results for anti-inflammatory activity ([Table 2](#medicines-04-00034-t002){ref-type="table"}), showed that the *T. vulgare* essential oil inhibited NO production (induced by LPS) with an IC~50~ of 72 µg·mL^−1^. Evaluation of the anti-inflammatory properties of the main compounds present in the oil showed that the most active compound was α-humulene with an IC~50~ of 15 µg·mL^−1^ ([Table 2](#medicines-04-00034-t002){ref-type="table"}). Fernandes et al. \[[@B27-medicines-04-00034]\] reported that α-humulene reduced rat paw edema that had been induced by carrageenan. It also inhibited COX-2 and iNOS expression. Moreover, the authors concluded that α-humulene might represent an important compound for the management and/or treatment of inflammatory diseases \[[@B27-medicines-04-00034]\]. Other compounds, including α-terpinene, α-pinene, and β-pinene were also effective with an IC~50~ ranging from 30 to 46 µg·mL^−1^ while caryophyllene oxide also inhibited NO production induced by LPS with an IC~50~ of 183 µg·mL^−1^. In a previous study, α-pinene was shown to inhibit NF-κB and JNK activation as well as the expression of iNOS \[[@B28-medicines-04-00034]\]. The anti-inflammatory properties of β-pinene and α-terpinene have also been reported \[[@B29-medicines-04-00034],[@B30-medicines-04-00034]\] as has caryophyllene oxide *in vivo* on mice models \[[@B31-medicines-04-00034]\].

The essential oil of *T. vulgare* demonstrated antioxidant activity by significantly inhibiting the oxidation of DCFH induced by tert-butylhydroperoxide with an IC~50~ of 51 µg·mL^−1^ ([Table 2](#medicines-04-00034-t002){ref-type="table"}). Using in vitro methods including DPPH, ABTS, and FRAP assays, Shaparov et al. \[[@B32-medicines-04-00034]\] also reported a moderate level of antioxidant activity of *T. vulgare* essential oil. Unfortunately, the chemical composition of the oil was not analyzed and the compounds responsible for the activity were not identified. The antioxidant activity of essential oils is often attributed to terpenoids such as carvacrol, thymol, and eugenol \[[@B33-medicines-04-00034]\]. However, our results for *T. vulgare* essential oil showed two compounds, α-pinene and caryophyllene oxide, to be particularly effective having a respective IC~50~ of 3.4 and 6.2 µg·mL^−1^. A moderate level of antioxidant activity for α-pinene, based on a DPPH assay, had been previously reported by Dai et al. \[[@B34-medicines-04-00034]\]. However, to the best of our knowledge, this is the first time the antioxidant activity of caryophyllene oxide has been reported.

Numerous *Tanacetum* species produce essential oils that are known to have antibacterial activity including *T. balsamita*, *T. polycephalum*, *T. parthenium*, *T. longifolium*, and *T. cilicicum* \[[@B35-medicines-04-00034],[@B36-medicines-04-00034],[@B37-medicines-04-00034]\]. Antibacterial activity of *T. vulgare* from Roumania \[[@B9-medicines-04-00034]\] and Slovakia \[[@B38-medicines-04-00034]\] were also reported against gram-positive bacterial strains using the disc diffusion method. Moreover, *T. vulgare* essential oil from Tajikistan was found to be weakly effective against *E. coli* and MRSA \[[@B32-medicines-04-00034]\]. In our study, we used a new antibiotic assay developed to test hydrophobic compounds as described in the Material and Methods section \[[@B25-medicines-04-00034]\]. The results, presented in [Table 2](#medicines-04-00034-t002){ref-type="table"}, show that *T. vulgare* essential oil was effective against *S. aureus* and *E. coli* with an IC~50~ of 59 µg·mL^−1^ and 241 µg·mL^−1^, respectively. We also tested the antibacterial activity of the main constituents of *T. vulgare* essential oil against *E. coli* and *S. aureus*. Camphor was active against both bacterial strains having an IC~50~ ranging from 22 to 26 µg·mL^−1^. Moreover, caryophyllene oxide and γ-terpinene were also active against *S. aureus* having a respective IC~50~ of 10.4 µg·mL^−1^ and 50 µg·mL^−1^. The antibacterial activity of camphor, caryophyllene oxide, and γ-terpinene has been previously reported in the literature \[[@B39-medicines-04-00034],[@B40-medicines-04-00034]\] although the results are sometimes contradictory. For example, Kotan et al. \[[@B41-medicines-04-00034]\] found camphor to be ineffective as an antibacterial compound. Our use of a new method that is better suited to hydrophobic matrices and compounds \[[@B25-medicines-04-00034]\] may explain the differences in the study outcomes.

We assessed the cytotoxic activity of *T. vulgare* essential oil and its main compounds against human lung carcinoma A-549, colon adenocarcinoma DLD-1, human keratinocytes *HaCaT*, and healthy WS1 cell lines. *T. vulgare* essential oil was slightly cytotoxic against A-549 and WS1 with an IC~50~ higher than 200 µg·mL^−1^ ([Table 2](#medicines-04-00034-t002){ref-type="table"}). Essential oil was also slightly cytotoxic against human keratinocytes *HaCaT* with an IC~50~ of 199 µg·mL^−1^. Interestingly, DLD-1 (colon adenocarcinoma) was more sensitive to *T. vulgare* essential oil than other cell lines, having an IC~50~ of 105 µg·mL^−1^. To the best of our knowledge, no studies have previously reported the cytotoxicity of *T. vulgare* essential oil against cancer cell lines. The major constituents of camphor, borneol, and 1,8-cineole, were all inactive with an IC~50~ \> 200 µg·mL^−1^. However, some minor compounds in the oil, including α-pinene, α-humulene, α-terpinene, β-caryophyllene, β-pinene, γ-terpinene, camphene, caryophyllene oxide, and limonene possessed a moderate cytotoxicity against all cell lines, including the tested cancer cell lines, with an IC~50~ ranging from 28 to 112 µg·mL^−1^. The cytotoxicity of these compounds against various cancer cell lines has also been previously reported \[[@B42-medicines-04-00034],[@B43-medicines-04-00034],[@B44-medicines-04-00034],[@B45-medicines-04-00034],[@B46-medicines-04-00034]\].

4. Conclusions {#sec4-medicines-04-00034}
==============

Analysis of the chemical composition of *T. vulgare* essential oil from northern Quebec, QC, Canada, demonstrated that it was mainly comprised of oxygenated monoterpene such as camphor, borneol, and 1,8-cineole. The essential oil inhibited NO production (stimulated by LPS and induced by RAW 264.7). The compound α-humulene was, in part, responsible for this anti-inflammatory effect. The antioxidant activity of the essential oil was, in part, due to α-pinene and caryophyllene oxide. Caryophyllene oxide (as well as camphor) was also responsible for antibiotic activity. Finally, *T. vulgare* essential oil inhibited the growth of colorectal cancer cells. In conclusion, *T. vulgare* essential oil possesses interesting biological properties. This study reports, for the first time, the links between the compounds found in *T. vulgare* essential oil and anti-inflammatory, antioxidant, antibacterial, and cytotoxic activities. Additional investigations of *T. vulgare* should be carried out for its potential use for cosmetic or pharmaceutical purposes.
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medicines-04-00034-t001_Table 1

###### 

Chemical composition of *T. vulgare* essential oil from northern Quebec, Canada.

  RI DB-5 ^1^   RI S-Wax ^2^   Identified Compounds          Relative CONCENTRATION (%)
  ------------- -------------- ----------------------------- ----------------------------
  903           991            Tricyclene                    0.11
  911           1010           α-Thujene                     0.58
  917           1006           α-Pinene                      4.43
  933           1035           Camphene                      7.29
  962           1085           Sabinene                      2.02
  965           1069           β-Pinene                      2.51
  982           1160           dehydro-1,8-Cineole           0.23
  1011          1148           α-Terpinene                   0.09
  1019          1242           ρ-Cymene                      1.20
  1023          1172           Limonene                      0.16 ^2^
  1025          1181           1,8-Cineole                   10.80 ^2^
  1053          1222           γ-Terpinene                   0.29
  1061          1443           *cis*-Sabinene hydrate        0.11
  1082          1254           Terpinolene                   0.09
  1096          1405           Filifolone                    0.15
  1100          1531           Linalol                       0.38
  1102          1386           α-Thujone                     0.08
  1109          1405           β-Thujone                     3.66
  1117          1468           Chrysanthenone                3.76
  1132          1614           *trans*-Pinocarveol           0.64
  1136          1471           Camphor                       30.48
  1153          1522           Pinocarvone                   0.27
  1160          1664           Borneol                       14.80
  1171          1570           Terpinen-4-ol                 0.81
  1176          1601           Thuj-3-en-10-al               0.45
  1185          1667           α-Terpineol                   0.69
  1187          1579           Myrtenal                      0.11
  1190          1752           Myrtenol                      0.09
  1216          1799           *trans*-Carveol               0.10
  1257          1539           *cis*-Chrysanthenyl acetate   0.10
  1282          1545           Bornyl acetate                5.53
  1352          2113           Eugenol                       0.16
  1370          1648           Isobornyl propionate          0.75
  1391          1880           *cis*-Jasmone                 0.08
  1411          1556           β-Caryophyllene               0.09
  1446          1629           α-Humulene                    0.21
  1475          1667           Germacrene D                  1.13
  1482          1674           β-Selinene                    0.12
  1491          1690           Bicyclogermacrene             0.16
  1496          1698           α-Muurolene                   ˂−Muuro
  1505          1701           β-Bisabolene                  0.09
  1499          1735           Germacrene A                  0.09
  1503          1721           δ-Amorphene                   0.17
  1509          1719           γ-Cadinene (1513)             0.15
  1519          1742           β-Sesquiphellandrene          0.17
  1522          1728           δ-Cadinene                    0.63
  1536          1865           α-Calacorene                  0.19
  1573          1922           Caryophyllene oxide           1.13
  1593          1976           Ledol                         0.65
  1597          1970           Rosifoliol                    0.07
  1622          2015           1-*epi*-Cubenol               0.05
  1624          2124           γ-Eudesmol                    0.11
  1631          2138           τ-Muurolol                    0.66
  1635          2131           τ-Cadinol                     0.19
  1641          2171           β-Eudesmol                    ˂−Eudes
  1647          2178           α-Cadinol                     0.05
  1663          2044           Valeranone                    0.07
  1713          1880           Pentadecanal                  ˂entade
  Total         99.23                                        

^1^ RI: Retention indices were obtained with a DB-5 column; ^2^ RI: Retention indices were obtained with a SolGel-Wax column.

medicines-04-00034-t002_Table 2

###### 

Anti-inflammation, antioxidant, antibacterial, and cytotoxic activities of *T. vulgare* essential oil and its main constituents

  Compounds             Anti-Inflammation IC~50~ (µg·mL^−1^)   Antioxidant IC~50~ (µg·mL^−1^)   Antibacterial IC~50~ (µg·mL^−1^)   Cytotoxicity IC~50~ (µg·mL^−1^)                           
  --------------------- -------------------------------------- -------------------------------- ---------------------------------- --------------------------------- ---------- ------------ ----------
  Essential oil         72 ± 9                                 51 ± 11                          241 ± 13                           59 ± 5                            232 ± 51   105 ± 18     292 ± 17
  1,8-Cineole           \>200                                  \>200                            \>200                              \>200                             \>200      \>200        \>200
  α-Humulene            15 ± 2                                 \>200                            \>200                              \>200                             28 ± 1     43 ± 3       24 ± 3
  α-Pinene              30 ± 4                                 3.4 ± 0.2                        nd                                 nd                                35 ± 6     58 ±18       57 ± 4
  α-Terpinene           46 ± 4                                 \>200                            \>200                              \>200                             63 ± 10    73 ± 7       53 ± 12
  β-Caryophyllene       \>200                                  \>200                            \>200                              \>200                             55 ± 5     97 ± 6       59 ± 7
  β-Pinene              46 ± 9                                 \>200                            \>200                              \>200                             43 ± 4     49.4 ± 0.3   29 ± 14
  γ-Terpinene           \>200                                  \>200                            \>200                              50 ± 9                            112 ± 15   \>200        82 ± 15
  p-Cymene              \>200                                  \>200                            \>200                              \>200                             \>200      \>200        \>200
  Borneol               \>200                                  \>200                            \>200                              \>200                             \>200      \>200        \>200
  Bornyl acetate        \>200                                  \>200                            \>200                              \>200                             \>200      \>200        \>200
  Camphene              \>200                                  \>200                            \>200                              \>200                             72 ± 2     75 ± 5       49 ± 1
  Camphor               \>200                                  \>200                            22 ± 1                             26 ± 3                            \>200      \>200        \>200
  Caryophyllene oxide   183 ± 15                               6.2 ± 0.5                        97 ± 2                             10.4 ± 0.9                        36 ± 2     43 ± 3       50 ± 4
  Limonene              \>200                                  \>200                            \>200                              \>200                             71 ± 6     31 ± 3       53 ± 12
  Terpinen-4-ol         \>200                                  \>200                            \>200                              \>200                             \>200      \>200        \>200
  Terpinolene           \>200                                  \>200                            \>200                              \>200                             \>200      \>200        \>200

nd: not determined; L-NAME (1 mM), used as an anti-inflammatory positive control, produced an inhibition of NO production of 64.1%; Quercetin, used as an antioxidant positive control, had an IC~50~ of 0.043 ± 0.002 µg·mL^−1^; Gentamycin and chloramphenicol were used as antibiotic positive controls. Gentamycin had an MIC~90~ of 0.9 ± 0.2 µg·mL^−1^ for *E. coli* and 0.0050 ± 0.00005 µg·mL^−1^ for *S. aureus*. Chloramphenicol had an MIC~90~ of 0.9 ± 0.1 µg·mL^−1^ for *E. coli* and 0.73 ± 0.03 µg·mL^−1^ for *S. aureus*; Etoposide, used as a cytotoxic positive control, had an IC~50~ of 2.3 ± 0.2 µM, 2.8 ± 0.4 µM and 19 ± 3 µM for A-549, DLD-1, and WS1, respectively; All the experiments were carried out in triplicate and presented results are representative of at least three different experiments.
